Comparing biopsy methods for prostate cancer detection
Part of Cancer, Kidney & urinary clinical trials.
This study compares two ways of taking prostate biopsies in men with suspected prostate cancer, to see which method finds cancer more accurately. Participation may help doctors choose the best biopsy approach for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult man aged 18 or older.
- You have signs that might indicate prostate cancer, like an abnormal digital rectal exam, family history, or elevated PSA levels.
- Your MRI shows a suspicious area (PI-RADS 3, 4, or 5) and if it's PI-RADS 3, your PSA density is high enough.
- Your PSA level is 20 ng/mL or lower.
- You have never had prostate cancer or a previous negative prostate biopsy.
- You can undergo a prostate biopsy and agree to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of doing prostate biopsies (sampling tissue from the prostate) to see if one is better. It is for men who have a suspicious MRI finding on one side of the prostate and have not had a biopsy before. Participation may help determine which method is more accurate and could influence future care.
This trial compares two ways to guide a prostate biopsy using MRI images, to see which better detects clinically significant prostate cancer in men with suspicious MRI findings.
This trial compares two ways to take a prostate biopsy (through the rectum or through the skin between the scrotum and anus) to see which is more accurate. Men with suspicious MRI findings (PI-RADS 3, 4, or 5) who haven't had prostate cancer before may be eligible.
This trial compares two ways of taking prostate biopsies to see which is more accurate at detecting cancer. Both use MRI images to guide the biopsy, which may help find cancer more precisely.
This study tests if a special MRI measurement (ADC) can improve how well a standard MRI finds prostate cancer. If you have a suspicious MRI and are scheduled for a biopsy, this might help better understand your results.
This study uses repeat MRI scans to monitor men with an intermediate suspicion of prostate cancer, aiming to reduce unnecessary biopsies while still catching significant cancers early.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.